Opinion|Videos|January 7, 2025
HPV Self-Collection Screening: What OB/GYNs Should Know
Author(s)Kameelah Phillips, MD, FACOG, NCMP
The panelist discusses the cautions around recent FDA approvals on human papillomavirus (HPV) self-collection, including limitations and sensitivity while emphasizing the importance of patients continuing to see their OB/GYN regularly.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the benefits and limitations of HPV self-collection, and who is it particularly designed for?
- How does the sensitivity of HPV self-collection compare with traditional collection methods?
- How can education about HPV and HPV screening influence screening rates?
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HIV screening, PrEP counseling get stronger ACOG recommendation
2
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
3
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
4
Closing the STI screening and follow-up gap in pregnancy, with Damian Alagia, III, MD
5